Loading the content... Loading depends on your connection speed!

Enter New Email
Confirm New Email
Enter Old Password
Enter New Password
Confirm New Password
 
Email sent successfully to:
Algorithm Information

Molecular Testing of Lung Adenocarcinoma | EGFR Mutation Testing

MyLikes

MyPaths
Purpose:
To identify a patient with a lung adenocarcinoma who may benefit from targeted therapy with specific tyrosine kinase inhibitors (TKI).
Specialty
  • Hematology Oncology
    Surgery
  • General
Pulmonology
Objective
  • Options
ICD-10
  • C34.9

In order to access the algorithms, please subscribe to a plan that fits your needs.

MyPaths
Cancel
Create Path
Create
Cancel
Create Note
Save
Molecular Testing of Lung Adenocarcinoma | EGFR Mutation Testing
Cancel
Save Data
Save
Limitation to 5 characters is for patient privacy.